Pfizer was accused of illegally marketing several of its drugs, including Bextra, Geodon, and Lyrica, for off-label uses that were not approved by the U.S. Food and Drug Administration (FDA). The company was also accused of paying kickbacks to doctors in exchange for prescribing their drugs, as well as making false and misleading statements about the safety and effectiveness of their products.